Jay Olson
Stock Analyst at Oppenheimer
(4.89)
# 290
Out of 4,556 analysts
1168
Total ratings
49.5%
Success rate
26.9%
Average return
Main Sectors:
Stocks Rated by Jay Olson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INO Inovio Pharmaceuticals | Rated: Hold | n/a | $1.06 | - | 2 | Jul 20, 2026 | |
| VRTX Vertex Pharmaceuticals | Rated: Hold | n/a | $472.57 | - | 8 | Jul 20, 2026 | |
| SKYE Skye Bioscience | Rated: Hold | n/a | $0.6402 | - | 15 | Jul 20, 2026 | |
| QTTB Q32 Bio | Maintained: Buy | $20 → $40 | $15.08 | +165.25% | 9 | Jul 13, 2026 | |
| KYNB Kyntra Bio | Initiated Coverage: Buy | $35 | $7.22 | +385.10% | 1 | Jul 7, 2026 | |
| CMPS COMPASS Pathways | Maintained: Buy | $20 | $11.93 | +67.64% | 4 | Jul 7, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Initiated Coverage: Buy | $23.93 | $9.10 | +162.93% | 1 | Jun 26, 2026 | |
| CHRS Coherus Oncology | Reiterated: Buy | $10 | $1.43 | +599.30% | 5 | Jun 22, 2026 | |
| DFTX Definium Therapeutics | Maintained: Buy | $40 → $60 | $43.67 | +37.39% | 6 | Jun 22, 2026 | |
| APRE Aprea Therapeutics | Initiated Coverage: Buy | $5 | $0.66 | +657.58% | 1 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $4.50 | +100.00% | 1 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $90 → $107 | $115.79 | -7.59% | 82 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $750 → $650 | $312.10 | +108.27% | 6 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $165 → $195 | $183.03 | +6.54% | 24 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $13.26 | +141.33% | 1 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $2.76 | +262.32% | 6 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $40 | $23.64 | +69.20% | 17 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 → $140 | $69.32 | +101.96% | 25 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $192 → $230 | $172.69 | +33.19% | 89 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $33 | $7.05 | +368.09% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $54.98 | - | 35 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $91.83 | - | 3 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.92 | - | 3 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 → $72 | $34.86 | +106.54% | 2 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $58.07 | - | 5 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $7.18 | +122.84% | 4 | Apr 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $250 → $275 | $197.74 | +39.07% | 98 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 → $36 | $4.21 | +755.11% | 31 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $4.47 | +571.14% | 11 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $21.94 | +173.47% | 1 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $650 | $537.65 | +20.90% | 50 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $380 → $400 | $366.05 | +9.27% | 83 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.38 | +334.78% | 4 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $2.38 | +194.12% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $27 | $11.13 | +142.59% | 26 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 | $54.01 | +66.64% | 14 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $37.31 | +168.02% | 38 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.84 | +334.78% | 5 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $3.10 | +480.65% | 20 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.44 | n/a | 67 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $0.7448 | n/a | 18 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $23.40 | n/a | 6 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $130.34 | n/a | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 | $13.06 | n/a | 35 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 | $24.96 | n/a | 36 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 | $47.24 | n/a | 24 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.78 | n/a | 19 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $0.9621 | n/a | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $10 | $29.99 | n/a | 6 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.34 | n/a | 10 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.70 | n/a | 16 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $5.00 | n/a | 9 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.54 | n/a | 10 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9511 | n/a | 6 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 8 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $9 | $2.02 | n/a | 45 | Aug 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $7 | $14.42 | n/a | 27 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.65 | n/a | 20 | Jul 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.27 | n/a | 19 | Mar 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.2339 | n/a | 6 | Mar 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.08 | n/a | 9 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.93 | n/a | 8 | Jan 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.59 | n/a | 5 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2 → $0.25 | $3.84 | n/a | 5 | Mar 30, 2016 |
Inovio Pharmaceuticals
Jul 20, 2026
Rated: Hold
Price Target: n/a
Current: $1.06
Upside: -
Vertex Pharmaceuticals
Jul 20, 2026
Rated: Hold
Price Target: n/a
Current: $472.57
Upside: -
Skye Bioscience
Jul 20, 2026
Rated: Hold
Price Target: n/a
Current: $0.6402
Upside: -
Q32 Bio
Jul 13, 2026
Maintained: Buy
Price Target: $20 → $40
Current: $15.08
Upside: +165.25%
Kyntra Bio
Jul 7, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $7.22
Upside: +385.10%
COMPASS Pathways
Jul 7, 2026
Maintained: Buy
Price Target: $20
Current: $11.93
Upside: +67.64%
Eupraxia Pharmaceuticals Inc.
Jun 26, 2026
Initiated Coverage: Buy
Price Target: $23.93
Current: $9.10
Upside: +162.93%
Coherus Oncology
Jun 22, 2026
Reiterated: Buy
Price Target: $10
Current: $1.43
Upside: +599.30%
Definium Therapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $40 → $60
Current: $43.67
Upside: +37.39%
Aprea Therapeutics
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $0.66
Upside: +657.58%
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $4.50
Upside: +100.00%
Jun 8, 2026
Maintained: Hold
Price Target: $90 → $107
Current: $115.79
Upside: -7.59%
Jun 2, 2026
Rated: Buy
Price Target: $750 → $650
Current: $312.10
Upside: +108.27%
Jun 1, 2026
Rated: Buy
Price Target: $165 → $195
Current: $183.03
Upside: +6.54%
May 28, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $13.26
Upside: +141.33%
May 11, 2026
Maintained: Buy
Price Target: $10
Current: $2.76
Upside: +262.32%
May 11, 2026
Maintained: Buy
Price Target: $35 → $40
Current: $23.64
Upside: +69.20%
May 8, 2026
Maintained: Buy
Price Target: $115 → $140
Current: $69.32
Upside: +101.96%
May 6, 2026
Rated: Buy
Price Target: $192 → $230
Current: $172.69
Upside: +33.19%
May 1, 2026
Rated: Buy
Price Target: $25 → $33
Current: $7.05
Upside: +368.09%
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $54.98
Upside: -
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $91.83
Upside: -
Apr 27, 2026
Rated: Hold
Price Target: n/a
Current: $4.92
Upside: -
Apr 22, 2026
Maintained: Buy
Price Target: $61 → $72
Current: $34.86
Upside: +106.54%
Apr 20, 2026
Rated: Hold
Price Target: n/a
Current: $58.07
Upside: -
Apr 5, 2026
Rated: Buy
Price Target: $16
Current: $7.18
Upside: +122.84%
Apr 1, 2026
Rated: Buy
Price Target: $250 → $275
Current: $197.74
Upside: +39.07%
Mar 18, 2026
Maintained: Buy
Price Target: $44 → $36
Current: $4.21
Upside: +755.11%
Mar 9, 2026
Reiterated: Buy
Price Target: $30
Current: $4.47
Upside: +571.14%
Feb 25, 2026
Initiated Coverage: Buy
Price Target: $60
Current: $21.94
Upside: +173.47%
Feb 9, 2026
Maintained: Buy
Price Target: $650
Current: $537.65
Upside: +20.90%
Jan 29, 2026
Maintained: Buy
Price Target: $380 → $400
Current: $366.05
Upside: +9.27%
Nov 13, 2025
Maintained: Buy
Price Target: $6
Current: $1.38
Upside: +334.78%
Nov 13, 2025
Maintained: Buy
Price Target: $7
Current: $2.38
Upside: +194.12%
Nov 7, 2025
Maintained: Buy
Price Target: $40 → $27
Current: $11.13
Upside: +142.59%
Oct 27, 2025
Maintained: Buy
Price Target: $90
Current: $54.01
Upside: +66.64%
Oct 7, 2025
Maintained: Buy
Price Target: $100
Current: $37.31
Upside: +168.02%
Oct 7, 2025
Maintained: Buy
Price Target: $8
Current: $1.84
Upside: +334.78%
Oct 2, 2025
Maintained: Buy
Price Target: $18
Current: $3.10
Upside: +480.65%
Jun 16, 2025
Maintained: Hold
Price Target: n/a
Current: $8.44
Upside: n/a
Jun 16, 2025
Maintained: Buy
Price Target: $65
Current: $0.7448
Upside: n/a
Mar 14, 2025
Downgraded: Hold
Price Target: n/a
Current: $23.40
Upside: n/a
Feb 12, 2025
Reiterated: Buy
Price Target: $115
Current: $130.34
Upside: n/a
Dec 10, 2024
Maintained: Hold
Price Target: $14
Current: $13.06
Upside: n/a
Nov 8, 2024
Maintained: Hold
Price Target: $17
Current: $24.96
Upside: n/a
Nov 6, 2024
Maintained: Buy
Price Target: $95
Current: $47.24
Upside: n/a
Nov 5, 2024
Reiterated: Hold
Price Target: n/a
Current: $2.78
Upside: n/a
Nov 4, 2024
Maintained: Buy
Price Target: $9
Current: $0.9621
Upside: n/a
Oct 17, 2024
Maintained: Buy
Price Target: $9 → $10
Current: $29.99
Upside: n/a
Feb 26, 2024
Rated: Hold
Price Target: n/a
Current: $1.34
Upside: n/a
Feb 14, 2023
Downgraded: Hold
Price Target: n/a
Current: $11.70
Upside: n/a
Nov 14, 2022
Upgraded: Buy
Price Target: $7
Current: $5.00
Upside: n/a
Aug 14, 2020
Rated: Hold
Price Target: n/a
Current: $10.54
Upside: n/a
Jun 12, 2020
Rated: Hold
Price Target: n/a
Current: $0.9511
Upside: n/a
May 8, 2020
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 22, 2019
Maintained: Buy
Price Target: $10 → $9
Current: $2.02
Upside: n/a
Aug 14, 2019
Maintained: Buy
Price Target: $15 → $7
Current: $14.42
Upside: n/a
Jul 22, 2019
Downgraded: Hold
Price Target: n/a
Current: $2.65
Upside: n/a
Mar 24, 2019
Maintained: Buy
Price Target: n/a
Current: $1.27
Upside: n/a
Mar 15, 2019
Rated: Hold
Price Target: n/a
Current: $0.2339
Upside: n/a
Dec 8, 2017
Rated: Hold
Price Target: n/a
Current: $4.08
Upside: n/a
Jan 20, 2017
Rated: Hold
Price Target: n/a
Current: $5.93
Upside: n/a
Dec 30, 2016
Reiterated: Hold
Price Target: n/a
Current: $10.59
Upside: n/a
Mar 30, 2016
Maintained: Sell
Price Target: $2 → $0.25
Current: $3.84
Upside: n/a